Ana Petković

Dr. Ana Petković

University Clinical Center, Serbia, Belgrade, Belgrade, Beograd, Serbia
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
APAna Petković
Ana Petković
NMNemanja Menković
Nemanja Menković
OPOlga Petrovic
Olga Petrovic
Ilija BilbijaIlija Bilbija
Ilija Bilbija
NRNikola Radovanovic
Nikola Radovanovic
BIBranislava Ivanovic
Branislava Ivanovic
Background: Infective endocarditis (IE) is a rare disease with a high mortality rate and rising incidence, requiring timely and precise diagnosis in order to choose appropriate therapy. Imaging of morphologic lesions is an integrative part of diagnosis. Artifacts and the patient’s habitus make echocardiography difficult to visualize advanced-form IE. Cardiac computed tomography (CCT) constantly shows an additive diagnostic value due to high resolution of cardiac anatomy. Conjecturally, joint application of both diagnostic tests improves overall sensitivity and specificity in diagnosing IE. Methods: Patients with definite IE underwent transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), and CCT. We analyzed valvular and paravalvular IE lesions in all three imaging methods and compared them to surgical or autopsy findings. We calculated sensitivity, specificity, diagnostic accuracy, and positive and negative predictive value of both imaging tests individually and jointly used. Results: We examined 78 patients, male to female ratio 2:1, mean age 52.29 ± 16.62. We analyzed 85 valves, 70 native valves, 13 prosthetic valves, and 2 corrected valves due to Ozaki procedure, along with a central shunt and 4 pacemaker leads. As a single test, the sensitivity and specificity of CCT, TTE, and TEE for valvular lesions were 91.6/20%, 65.5/57.9%, and 60/84%, and paravalvular lesions were 100/0%, 46/10.5%, and 14.7/100%. When combined together, sensitivity and specificity for valvular lesions rose to 96.6/0% and paravalvular lesions to 100/0%. We also analyzed the diagnostic performance for each test in single and mutual application, per specific IE lesion. Conclusion: In the individual application, CCT in comparison to TTE and TEE shows better diagnostic performance in detection of valvular and paravalvular lesions. In joint application, there is a statistically significant difference in performance compared to their single use, especially in prosthetic valves and invasive forms of IE native valves.

26 June 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
APAna Petković
Ana Petković
NMNemanja Menković
Nemanja Menković
OPOlga Petrovic
Olga Petrovic
Ilija BilbijaIlija Bilbija
Ilija Bilbija
MNMiodrag Nišević
Miodrag Nišević
BIBranislava Ivanovic
Branislava Ivanovic
Infective endocarditis is a rare disease with an increasing incidence and an unaltered high mortality rate, despite medical development. Imaging plays an integrative part in the diagnosis of infective endocarditis, with echocardiography as the initial diagnostic test. Research data in the utility of cardiac computed tomography (CCT) in the diagnostic algorithm of IE are rising, which indicates its importance in detection of IE-related lesion along with the exclusion of coronary artery disease. The latest 2023 European Society of Cardiology Guidelines in the management of IE classified CCT as class of recommendation I and level of evidence B in detection of both valvular and paravalvular lesions in native and prosthetic valve endocarditis. This review article provides a comprehensive and contemporary review of the role of CCT in the diagnosis of IE, the optimization of acquisition protocols, the morphology characteristics of IE-related lesions, the published data of the diagnostic performance of CCT in comparison to echocardiography as the state-of-art method, as well as the limitations and future possibilities.


28 January 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
Maja StojanovicMaja Stojanovic
Maja Stojanovic
Aleksandra BaracAleksandra Barac
Aleksandra Barac
APAna Petković
Ana Petković
NVNikola Vojvodic
Nikola Vojvodic
SOStrahinja Odalovic
Strahinja Odalovic
MSMihailo Stjepanovic
Mihailo Stjepanovic
Giant cell arteritis (GCA) is an immune-mediated vasculitis that affects large arteries. It has been hypothesized that viruses may trigger inflammation within the vessel walls. Genetic studies on human leukocyte antigens (HLAs) have previously reported HLA-DRB1*04 as a susceptible allele for GCA and HLA-DRB1*15 as a protective allele for GCA. Here, we discuss the clinical presentation, laboratory findings, HLA class I and class II analysis results, and management of patients with extracranial large-vessel (LV) GCA, detected at least six weeks after recovery from COVID-19. This case series encompassed three patients with LV-GCA (two males and a female with an age range of 63–69 years) whose leading clinical presentation included the presence of constitutional symptoms and significantly elevated inflammatory markers. The diagnosis of LV-GCA was confirmed by CT angiography and FDG-PET/CT, revealing inflammation in the large vessels. All were treated with corticosteroids, while two received adjunctive therapy. By analyzing HLA profiles, we found no presence of the susceptible HLA-DRB1*04 allele, while the HLA-DRB1*15 allele was detected in two patients. In conclusion, LV-GCA may be triggered by COVID-19. We highlight the importance of the early identification of LV-GCA following SARS-CoV-2 infection, which may be delayed due to the overlapping clinical features of GCA and COVID-19. The prompt initiation of therapy is necessary in order to avoid severe vascular complications. Future studies will better define the role of specific HLA alleles in patients who developed GCA following COVID-19.

1 January 2024
Verified
Conference Paper
Closed access
APAna Petković
Ana Petković
Obeležja Takayasu arteritisa (TA) su inflamacija arterijskog zida sa naknadnim remodelovanjem i predispozicijom za razvoj arterijske stenoze i/ili dilatacije. Stepen oštećenja arterije je usko povezan sa prognozom i stoga je njegova prevencija preovlađujući cilj terapije. Neinvazivno snimanje je značajno poboljšalo našu sposobnost da identifikujemo obim i težinu bolesti i da pratimo njenu evoluciju. Međutim, ostaje mnogo pitanja u vezi sa optimalnom upotrebom pojedinačnih imidžing modaliteta u različitim stadijumima bolesti. Nedostaju metode snimanja za kvantifikaciju arterijskog oštećenja. Slično tome, nijedna tehnika ne može precizno odrediti aktivnost bolesti unutar arterijskog zida ili razlikovati inflamatornu i neinflamatornu progresiju bolesti. Kompjuterizovana tomografija (CT) angiografija se koristi za procenu lumena krvnih sudova i njihovih zidova, omogućavajući dijagnozu u ranim fazama bolesti mnogo pre pojave značajnog suženja lumena krvnog suda. Na osnovu kvalitativnih radioloških kriterijuma, u analizi zida zahvaćenog krvnog suda, moguće je napraviti jasnu distinkciju TA od aterosklerotične bolesti i delimično odrediti stepen aktivnosti bolesti. Na osnovu kvantitativnih radioloških kriterijuma, moguće je odrediti stepen i obim razvoja bolesti. U poslednjih nekoliko godina, CT koronarografija postaje deo rutinske kliničke prakse, u cilju procene prisustva i obima zahvaćenosti koronarnih arterija u okviru TA. Cilj ovog izlaganja je da se prikažu trenutne strategije snimanja kod Takayasu arteritisa iz ugla komjuterizovane tomografije, njenu ulogu u dijagnozi i praćenju bolesti i potencijalnom budućem napredku.

14 November 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
OPOlga Petrovic
Olga Petrovic
DZDimitrije Marko Zrnic
Dimitrije Marko Zrnic
SVStaša Vidanović
Staša Vidanović
INIvana P Nedeljkovic
Ivana P Nedeljkovic
ONOlga Milos Nedeljkovic-Arsenovic
Olga Milos Nedeljkovic-Arsenovic
DTDanijela Trifunovic-Zamaklar
Danijela Trifunovic-Zamaklar
Background/Objectives: Moderate aortic stenosis (AS) with preserved ejection fraction (EF) is common, yet risk stratification remains challenging. Cardiopulmonary exercise testing (CPET) and myocardial mechanics analysis may identify subclinical dysfunction and impaired functional capacity. To evaluate the relationship between functional capacity (by % predicted peak VO2), ventilatory efficiency (VE/VCO2 slope), and myocardial mechanics (speckle tracking echocardiography—STE), and myocardial work (MW) indices) in moderate AS with preserved EF. Methods: We prospectively enrolled 107 patients with moderate AS (AVA 1.0–1.5 cm2; mean gradient 20–40 mmHg; EF ≥ 50%). Functional capacity was classified as preserved (≥83% predicted VO2) or reduced (<83%). Ventilatory efficiency was defined as good (<30) or poor (≥30) VE/VCO2 slope. STE assessed left ventricular (LV), left atrial (LA), and right ventricular (RV) strain, as well as myocardial work indices. Results: Patients with reduced % predicted VO2 had higher LV end-systolic volume (p = 0.035), lower stroke volume index (p = 0.020), and smaller indexed aortic valve area (p = 0.025), with trends toward lower GLS and myocardial work. In contrast, patients with poor ventilatory efficiency (VE/VCO2 ≥ 30) showed significant impairments in global longitudinal strain (GLS, p = 0.002), LA reservoir strain (PALS, p = 0.019) and LA conduit strain (LA Scd, p < 0.001), RV free wall strain (RW FWS, p = 0.029), and myocardial work indices (lower GWI and GCW, higher GWW, reduced GWE; all p < 0.05). LA Scd emerged as the strongest predictor of poor ventilatory efficiency. (receiver operating characteristic (ROC) area under the curve (AUC) 0.723, 95% confidence interval (CI) 0.623–0.823, p < 0.001). Conclusions: In moderate AS with preserved EF, impaired ventilatory efficiency is more strongly associated with subclinical LV, LA, and RV dysfunction than reduced % predicted VO2, highlighting the key role of RV impairment. Integrating CPET and STE improves phenotyping, identifying high-risk patients who may benefit from closer surveillance or early intervention. These findings are exploratory and hypothesis-generating; longitudinal data are needed to confirm prognostic implications.